Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment

Although gemifloxacin has low in vitro activity against Mycobacterium tuberculosis, the effect of gemifloxacin on the delay of tuberculosis (TB) treatment has not been validated in a clinical setting. The study group included patients with culture-confirmed pulmonary TB who initially received gemifl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo Yun, Yim, Jae-Joon, Park, Jong Sun, Park, Sung Soo, Heo, Eun Young, Lee, Chang-Hoon, Chung, Hee Soon, Kim, Deog Kyeom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594600/
https://www.ncbi.nlm.nih.gov/pubmed/23486643
http://dx.doi.org/10.3346/jkms.2013.28.3.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594600/
https://www.ncbi.nlm.nih.gov/pubmed/23486643
http://dx.doi.org/10.3346/jkms.2013.28.3.378

Ejemplares similares